Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

  • 1,
  • 2,
  • 3Email author,
  • 3,
  • 1,
  • 2,
  • 2,
  • 2,
  • 4,
  • 2 and
  • 2
Contributed equally
Breast Cancer Research201820:107

https://doi.org/10.1186/s13058-018-1038-3

  • Published:

The original article was published in Breast Cancer Research 2018 20:78

Correction

After the publication of this article [1], we noticed that in Fig. 2, the survival curve images (C and D, lower panel) were incorrect. The corrected Fig. 2 is presented below. The correction does not affect in any our results and conclusions.
Fig. 2
Fig. 2

Survival curves. a Disease-free survival (DFS). b Overall survival (OS). c DFS stratified by estrogen receptor (ER) status. d OS stratified by ER status. The tentative cutoff value of 1.48 separates tumors with higher 18F-fluoromisonidazole tissue-to-blood ratio (TBR high) from those with lower 18F-fluoromisonidazole tissue-to-blood ratio (TBR low)

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Breast Oncology, Saitama Medical University Hospital, 38 Morohongo, Moroyama-machi, Irumagun, Saitama 350-0451, Japan
(2)
Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1241, Japan
(3)
Department of Nuclear Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1241, Japan
(4)
Department of Pathology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1241, Japan

Reference

  1. Asano A, Ueda S, Kuji I, Yamane T, Takeuchi H, Hirokawa E, Sugitani I, Shimada H, Hasebe T, Osaki A, et al. Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer. Breast Cancer Res. 2018;20(1):78.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement